At the bench: Engineering the next generation of cancer vaccines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

At the bench: Engineering the next generation of cancer vaccines

Published:2019-08-20 Issue:4 Volume:108 Page:1435-1453
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:J Leukoc Biol

Author:

Shae Daniel¹,Baljon Jessalyn J.²,Wehbe Mohamed¹,Becker Kyle W.¹^ORCID,Sheehy Taylor L.¹,Wilson John Tanner¹²³⁴⁵^ORCID

Affiliation:

1. Department of Chemical and Biomolecular Engineering Vanderbilt University Nashville Tennessee USA

2. Department of Biomedical Engineering Vanderbilt University Nashville Tennessee USA

3. Vanderbilt Institute for Infection, Immunology, and Inflammation Vanderbilt University Medical Center Nashville Tennessee USA

4. Vanderbilt Center for Immunobiology Vanderbilt University Medical Center Nashville Tennessee USA

5. Vanderbilt‐Ingram Cancer Center Vanderbilt University Medical Center Nashville Tennessee USA

Funder

American Cancer Society

National Science Foundation

Melanoma Research Alliance

Stand Up To Cancer

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/JLB.5BT0119-016R

Reference225 articles.

1. Cancer immunotherapy: moving beyond current vaccines

2. Therapeutic cancer vaccines: are we there yet?

3. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

4. Immune Checkpoint Blockade in Cancer Therapy

5. Monitoring immune-checkpoint blockade: response evaluation and biomarker development

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges;Acta Pharmaceutica Sinica B;2024-09

2. Enhancing in situ cancer vaccines using delivery technologies;Nature Reviews Drug Discovery;2024-07-01

3. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists;ACS Nano;2024-02-22

4. Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy;The Journal of Immunology;2024-01-15

5. Tumor-derived autophagosome vaccines combined with immune adjuvants mediate antitumor immune responses via the neoantigen pathway;Neoplasma;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3